





Tirz 15mg
Tirzepatide is a novel dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is a synthetic peptide designed to mimic the effects of endogenous incretin hormones that regulate glucose metabolism, appetite, and energy balance.
Compound Name: Tirzepatide
Concentration: 15 mg
Form: Lyophilized peptide powder
Volume: Suitable for reconstitution in 3 mL bacteriostatic water (typical)
Purity: ≥99%
Storage: Store at -20°C; protect from light and moisture
Shelf Life: Up to 24 months if unopened and properly stored
Intended Use:
For laboratory research only. Not for human consumption.
Tirzepatide 15 mg is provided for preclinical studies, biochemical pathway analysis, or academic research investigating receptor activity, metabolic function, or peptide pharmacodynamics.
Tirzepatide is a novel dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is a synthetic peptide designed to mimic the effects of endogenous incretin hormones that regulate glucose metabolism, appetite, and energy balance.
Compound Name: Tirzepatide
Concentration: 15 mg
Form: Lyophilized peptide powder
Volume: Suitable for reconstitution in 3 mL bacteriostatic water (typical)
Purity: ≥99%
Storage: Store at -20°C; protect from light and moisture
Shelf Life: Up to 24 months if unopened and properly stored
Intended Use:
For laboratory research only. Not for human consumption.
Tirzepatide 15 mg is provided for preclinical studies, biochemical pathway analysis, or academic research investigating receptor activity, metabolic function, or peptide pharmacodynamics.
Tirzepatide is a novel dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is a synthetic peptide designed to mimic the effects of endogenous incretin hormones that regulate glucose metabolism, appetite, and energy balance.
Compound Name: Tirzepatide
Concentration: 15 mg
Form: Lyophilized peptide powder
Volume: Suitable for reconstitution in 3 mL bacteriostatic water (typical)
Purity: ≥99%
Storage: Store at -20°C; protect from light and moisture
Shelf Life: Up to 24 months if unopened and properly stored
Intended Use:
For laboratory research only. Not for human consumption.
Tirzepatide 15 mg is provided for preclinical studies, biochemical pathway analysis, or academic research investigating receptor activity, metabolic function, or peptide pharmacodynamics.
Compound Name: Tirzepatide (LY3298176)
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight: 4,813.45 g/mol
CAS Number: 2023788-19-2
Sequence: 39-amino acid linear peptide with a C20 fatty diacid moiety attached via a linker to lysine at position 20
Tirzepatide is a synthetic peptide analog that combines the sequences of two incretin hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). The molecule includes a 39-amino acid linear peptide chain with a C20 fatty diacid moiety attached via a linker to lysine at position 20, enhancing its half-life by promoting albumin binding.
Note: Due to the complexity of the molecule, a visual representation of the chemical structure is recommended for detailed analysis.
Mechanism of Action: Tirzepatide functions as a dual agonist for GIP and GLP-1 receptors. By activating both receptors, it enhances insulin secretion, suppresses glucagon levels, and slows gastric emptying, leading to improved glycemic control and potential weight loss. The dual receptor activity may provide synergistic effects compared to single receptor agonists.
Storage & Handling
Form: Lyophilized powder
Storage Conditions: Store at -20°C; protect from light and moisture
Shelf Life: Up to 24 months if unopened and properly stored
Reconstitution: Recommended to reconstitute with sterile water or appropriate solvent prior to use